Journals / Mikrobiyoloji Bülteni / 2005 / Cilt: 39 - Sayı: 3

Comparison of different phenotypic methods detecting extended spectrum beta-lactamases in Pseudomonas aeruginosa and Acinetobacter baumannii strains

Pseudomonas aeruginosa ve Acinetobacter baumannii suşlarında genişlemiş spektrumlu beta-laktamaz varlığının saptanmasında farklı fenotipik yöntemlerin karşılaştırılması

Pages
265–272
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, E-test method was found to be the most sensitive phenotypic method for the detection of ESBL in our study collection.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pseudomonas aeruginosa and Acinetobacter baumannii which are of great concern as the frequent causative agents of nosocomial infections, frequently exhibit resistance to beta-lactam antibiotics.
📊
Key Findings & Data:The aim of this study was to compare the results of Epsilomer test (E-test), combined disk (CD) and double disk synergy (DDS) methods for the detection of ESBL in a total of 38 P.aeruginosa and 45 A.baumannii strains with ceftazidim or cefotaxime MIC >1 jig/ml, isolated from different clinical samples.
💡
Conclusion & Impact:In conclusion, E-test method was found to be the most sensitive phenotypic method for the detection of ESBL in our study collection.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Anti-bakteriyel ajanlar · beta-Laktamazlar · Seftazidim

Abstract

Pseudomonas aeruginosa and Acinetobacter baumannii which are of great concern as the frequent causative agents of nosocomial infections, frequently exhibit resistance to beta-lactam antibiotics. One of the most common causes of this resistance is the presence of extended spectrum beta-lactamases (ESBL). There is still no standardized method for the detection of ESBLs in P.aeruginosa and A.baumannii strains. The aim of this study was to compare the results of Epsilomer test (E-test), combined disk (CD) and double disk synergy (DDS) methods for the detection of ESBL in a total of 38 P.aeruginosa and 45 A.baumannii strains with ceftazidim or cefotaxime MIC >1 jig/ml, isolated from different clinical samples. Cefepime was included in the group of indicator antibiotics and the distance between ciavuianic acid containing disk and indicator antibiotic disks was reduced to increase the sensitivity of DDS test. Of the P.aeruginosa strains, 78.9% was detected as ESBL producers by ceftazidime/ ceftazidime-clavulanic acid and 21.1% detected by cefotaxime/cefotaxime-clavulanic acid ratio. Among this group of strains, 31.5% was positive by DDS test and 84.2% was positive by CD method. Of the Abaumannii strains, 93.3% of them was positive by ceftazidime/ceftazidime-clavulanic acid and 6.6% was positive by cefotaxime/cefotaxime-clavulanic acid ratio. DDS test detected 20% and CD method detected 53.3% of the strains positive by E-test method. The use of cefotaxime together with ceftazidime as an indicator antibiotic increased the sensitivity of detection of ESBL enzymes. Although inclusion of cefepime and reduction of the distance between disks increased the detection of ESBL by DDS method, it was still less effective than E-test. Although, 28.9% of the P.aeruginosa and 13.3% of \he Abaumannii strains were susceptible to ceftazidime by in vitro tests, they were ESBL producers. In conclusion, E-test method was found to be the most sensitive phenotypic method for the detection of ESBL in our study collection.

Özet

Hastane enfeksiyonu etkeni bakteriler içinde önemli bir yer tutan Pseudomonas aeruginosa ve Acinetobacter baumannii suşlannda genişlemiş spektrumlu beta-laktamaz (GSBL) varlığını saptayan yöntemler henüz standardize edilmemiştir. Bu çalışmada, farklı klinik örneklerden izole edilen seftazidim veya sefotaksim MİK değeri >1 pg/ml üzerinde olan 38 P. aeruginosa ve 45 A. baumannii izolatında GSBL varlığının saptanması amacıyla, Epsilomer test (E-test), kombine disk (KD) ve çift disk sinerji (ÇDS) yöntemlerinin karşılaştırılması planlanmıştır. ÇDS yönteminin duyarlılığını artırmak amacıyla indikatör antibiyotikler içerisine sefepim dahil edilmiş, klavulanik asit içeren disk ile indikatör antibiyotikler arasındaki mesafe kısaltılarak değerlendirme yapılmıştır. P.aeruginosa suşlarının %78.9'u seftazidim/seftazidim+klavulanik asit, %21.1'i sefotaksim/sefotaksim+klavulanik asit oranına göre E-test yöntemiyle GSBL pozitif olarak değerlendirilmiştir. Bu izolatların %31.5'inde ÇDS yöntemiyle, %84.2'sinde KD yöntemiyle GSBL enziminin varlığı tespit edilmiştir. Abaumannii suşlarının ise %93.3'ü seftazidim/seftazidim+klavulanik asit, %6.6'sı sefotaksim/ sefotaksim+klavulanik asit oranına göre E-test yöntemiyle GSBL pozitif olarak değerlendirilmiştir. Bu izolatların da %20'sinde ÇDS yöntemiyle, %53.3'ünde KD yöntemiyle GSBL enziminin varlığı belirlenmiştir. Gerek E-test gerekse KD yöntemlerinde seftazidimle birlikte sefotaksimin de indikatör antibiyotik olarak kullanılmasının testin duyarlılığını artırdığı gözlenmiştir. ÇDS yönteminde sefepim kullanılması ve diskler arası mesafenin kısaltılması pozitiflik oranını artırmış, ancak E-test yöntemine kıyasla enzim saptanmasında yetersiz kalmıştır. P.aeruginosa suşlarının %28.9'u, Abaumannii suşlarının ise %13.3'ü GSBL sentezlemesine rağmen in vitro olarak seftazidime duyarlı bulunmuştur. Sonuç olarak, P.aeruginosa ve A.baumannii suşlarında GSBL varlığının saptanması için E-test yönteminin en duyarlı fenotipik yöntem olduğu gözlenmiştir.

🔖

Cite This Article

ZARAKOLU, P., METAN, G., HASÇELİK, G., AKOVA, M. (2005). Comparison of different phenotypic methods detecting extended spectrum beta-lactamases in Pseudomonas aeruginosa and Acinetobacter baumannii strains. Mikrobiyoloji Bülteni, Cilt: 39 - Sayı: 3, 265–272. https://ajindex.com/articles/299860

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Bradford PA: Extended spectrum beta-lactamases in the 21st century: Characterization, epidemiology and detection of this important resistance threat. Clin Microbiol Rev 2001, 14: 933-951
  2. Palucha A, Mikiewicz B, Gniadkowski M: Diversification of Escherichia coli expressing an SHV-type extended-spectrum beta-lactamase (ESBL) during a hospital outbreak: emergence of an ESBL-hyperproducing strain resistant to expanded-spectrum cephalosporins. Antimicrob Agents Chemother 1999, 43: 393-396
  3. Weiner J, Quinn JP, Bradford PA, et al: Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999, 281: 517-523
  4. Sardan YC, Zarakolu P, Altun B, Yıldırım A, Yıldırım G, Hasçelik G, Uzun O: A cluster of nosocomial Klebsiella oxytoca bloodstream infections in a university hospital. Infect Control Hosp Epidemiol 2004, 25: 878-882
  5. Poirel L, Weldhagen GF, De Champs C, Nordmann P: A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended-spectrum beta-lactamase GES-2 in South Africa. J Antimicrob Chemother 2002, 49: 561-565
  6. Poirel L, Menuteau O, Agoli N, Cattoen C, Nordmann P: Outbreak of extended-spectrum beta- lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol 2003, 41: 3542-3547
  7. Vahapoglu H, Ozturk R, Tansel O, et al: Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob Agents Chemother 1997, 41: 2265-2269
  8. Vahapoglu H, Coskunkan F, Tansel O, et al: Clinical importance of extended-spectrum beta-lactamase (PER-l-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains. J Med Microbiol 2001, 50: 642-645
  9. Sturenburg E, Mack D: Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect 2003, 47: 273-295
  10. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disk susceptibility tests. Approved Standard M2-A7, 7th ed. 2000. NCCLS, Wayne, Pennsylvania
  11. Livermore DM, Brown DF: Detection of beta-lactamase-mediated resistance. J Antimicrob Chemother 2001, 48 (Suppl 1): 59-64
  12. M'Zali FH, Chanawong A, Kerr KG, Birkenhead D, Hawkey PM: Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the MAST DD test, the double disc and the E-test E